|
By clicking to begin a simulation, you are acknowledging that you have reviewed the CME information below.
Cases Developed by Expert Faculty
Clete A. Kushida, MD, PhD, RPSGT, Stanford University
John W. Winkelman, MD, PhD, Brigham and Women's Hospital
Release Date
November 14, 2008 (valid until November 13, 2009)
Introduction
Sleep disorders such as obstructive sleep apnea syndrome, restless legs syndrome/periodic limb movement, and insomnia are common in the United States with an estimated 60 million Americans experiencing symptoms such as fatigue, irritability, decreased memory and concentration, and pervasive malaise each year. Sleep disorders have a significant negative impact on work, physical, and social performance and overall quality of life and contribute to more than 50,000 unnecessary deaths each year. The total direct, indirect, and related costs of sleep disorders are conservatively estimated at as much as $107.5 billion annually.
Target Audience
This activity is specifically designed for primary care clinicians who manage patients with sleep disturbances.
Learning Objectives
Upon completing this educational activity, participants should be able to:
- Discuss the clinical features, epidemiology, and pathophysiology of Restless Leg Syndrome (RLS)
- Develop the appropriate evaluative skills for an accurate, informed and confident differential diagnosis of RLS
- Describe important considerations when selecting treatments for RLS
Accreditation Statement
 This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the CME LLC and CASIVUS Specialty Communications. The CME LLC Institute is accredited by the ACCME to provide continuing medical education for physicians.
The CME LLC Institute designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™ for physicians, 0.5 credits maximum per case.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Faculty
Clete A. Kushida, MD, PhD, RPSGT
Acting Medical Director, Stanford Sleep Disorders Clinic
Stanford University
Disclosure
Dr. Kushida has received research support from GlaxoSmithKline, Kyowa Pharmaceuticals, Schwarz Pharmaceuticals, and XenoPort.
John W. Winkelman, MD, PhD
Medical Director, Sleep Health Center
Brigham and Women's Hospital
Disclosure
Dr. Winkelman is on the advisory board for Axon Labs, Boehringer Ingelheim, GlaxoSmithKline, Jazz Pharmaceuticals, Novartis, Takeda, and Schwarz Pharmaceuticals; is on the Speakers Bureau for Boehringer Ingelheim, GlaxoSmithKline, sanofi-aventis, Sepracor, and Takeda; Research Support for Boehringer Ingelheim, Schwarz Pharmaceuticals, and Sepracor.
Disclaimer
The information provided during this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To earn credit, participants must complete the activity online by November 13, 2009
Hardware/Software Requirements
The simulation requires version 4.x browsers or higher from Microsoft or Netscape or Mozilla FireFox version 1.5.x or higher. Certain activities may require additional software to view multimedia, presentation or printable versions of their content. There are no specific hardware requirements.
|
